Internal Medicine, Medical Oncology · Cape Girardeau, MO
NPI
1992755441
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
211 Saint Francis Dr, Suite 372
Cape Girardeau, MO, 63703
Phone (573) 331-5525
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
2,439 services
Medicare patients, 2024
464
Average age 75
Drug cost, 2024
$2.8M
1,398 prescriptions
Company payments, 2025
$1,537
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos Robles was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,129 times for 407 patients. In total Carlos Robles billed 2,439 services in 13 codes, and Medicare paid $108K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 1,129 | 407 | $12.16 | $14K |
| 99214 Office E&M - Established | Facility | 954 | 322 | $68.13 | $65K |
| 99213 Office E&M - Established | Facility | 120 | 110 | $40.27 | $4,832 |
| 99215 Office E&M - Established | Facility | 105 | 71 | $108.10 | $11K |
| 99204 Office E&M - New | Facility | 49 | 49 | $93.64 | $4,588 |
| 99205 Office E&M - New | Facility | 38 | 38 | $132.32 | $5,028 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $100.66 | $1,107 |
By year: 2022 $105K for 1,434 services; 2023 $101K for 1,354 services; 2024 $108K for 2,439 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos Robles prescribed most often to Medicare patients was Anastrozole, with 154 prescriptions and refills. In total Carlos Robles wrote 1,398 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 154 | 258 | 31 | $1,843 |
| Dexamethasone Generic | 107 | 112 | 33 | $1,481 |
| Ondansetron Hcl Generic | 102 | 104 | 47 | $4,027 |
| Prochlorperazine Maleate Generic | 73 | 73 | 40 | $884 |
| Letrozole Generic | 65 | 114 | 12 | $777 |
| Hydroxyurea Generic | 53 | 101 | 11 | $2,383 |
| Tamoxifen Citrate Generic | 51 | 60 | Under 11 | $514 |
| Acyclovir Generic | 43 | 63 | Under 11 | $343 |
| Eliquis Apixaban | 41 | 42 | Under 11 | $22K |
| Revlimid Lenalidomide | 41 | 41 | Under 11 | $744K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | 19 | $867 |
| Levothyroxine Sodium Generic | 31 | 63 | Under 11 | $174 |
| Potassium Chloride Generic | 30 | 36 | Under 11 | $185 |
| Folic Acid Generic | 28 | 44 | Under 11 | $167 |
| Lorazepam Generic | 26 | 28 | Under 11 | $46.26 |
Brand drugs: - claims; generic drugs: 1,161 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos Robles $1,537 ($1,537 in general payments such as food, travel and fees) from 22 companies. The largest payer was Janssen Biotech, Inc. with $209.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $209 |
| EMD Serono, Inc. MRK.DE | 7 | $201 |
| Gilead Sciences, Inc. GILD | 7 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $160 |
| Eisai Inc. 4523.T | 2 | $145 |
| Incyte Corporation INCY | 1 | $125 |
| Amgen Inc. AMGN | 2 | $62.22 |
| GlaxoSmithKline, LLC. GSK | 2 | $51.46 |
| Pfizer Inc. PFE | 2 | $50.03 |
| Dendreon Pharmaceuticals LLC | 1 | $34.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.